After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Immunome Inc is $2.40B. A total of 4.02 million shares were traded on the day, compared to an average of 1.94M shares.
In the most recent transaction, Barchas Isaac sold 383,200 shares of IMNM for 21.74 per share on Dec 22 ’25. After the transaction, the Director now owns 2,031,181 company shares. In a previous transaction on Dec 19 ’25, SIEGALL CLAY B bought 7,278 shares at 20.48 per share. IMNM shares that President and CEO owns now total 860,525.
Among the insiders who bought shares, Tsai Philip acquired of 10,000 shares on Dec 19 ’25 at a per-share price of $20.49. This resulted in the Chief Technical Officer holding 43,300 shares of IMNM after the transaction. In another insider transaction, SIEGALL CLAY B bought 46,511 shares at $21.50 per share on Dec 18 ’25. Company shares held by the President and CEO now total 853,247.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IMNM has a high of $25.30 and a low of $5.15.
As of this writing, IMNM has an earnings estimate of -$0.57 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.72. The company reported an EPS of -$1.11 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $2.88, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMNM is Buy with a score of 4.86.
